EP 2588139 A1 20130508 - NEW COMBINATION TREATMENT FOR TYPE 2 DIABETES AND OTHER DISORDERS RELATED TO INSULIN RESISTANCE
Title (en)
NEW COMBINATION TREATMENT FOR TYPE 2 DIABETES AND OTHER DISORDERS RELATED TO INSULIN RESISTANCE
Title (de)
NEUE KOMBINATIONSTHERAPIE FÜR TYP-2-DIABETES UND ANDERE ERKRANKUNGEN IM ZUSAMMENHANG MIT INSULINRESISTENZ
Title (fr)
NOUVELLE COMBINAISON DE TRAITEMENTS POUR DIABÈTE DE TYPE 2 ET AUTRES TROUBLES LIÉS À RÉSISTANCE À L'INSULINE
Publication
Application
Priority
NL 2010050326 W 20100528
Abstract (en)
[origin: WO2011149337A1] The invention relates to a new pharmaceutical composition comprising metformin, vitamin B12 (a-(5,6-dimethylbenzimidazolyl) cobamidcyanide or cyanocobalamin) or a vitamin B12 equivalent, vitamin B1 (thiamine) or a vitamin B1 equivalent, and optionally vitamin D (25-OH D3) or a vitamin D equivalent, further optionally calcium, and further optionally chromium, and the use of such a composition in the treatment of type 2 diabetes, prediabetes, insulin resistance, metabolic syndrome, cancer, high risk patients for cardiovascular disease, NASH, gestational diabetes, Poly Cystic Ovary Syndrome, type 1 diabetes and patients with (a high risk to develop) cancer.
IPC 8 full level
A61K 45/06 (2006.01); A61K 33/24 (2019.01)
CPC (source: EP US)
A61K 31/155 (2013.01 - EP); A61K 31/51 (2013.01 - EP); A61K 31/593 (2013.01 - EP); A61K 31/714 (2013.01 - EP); A61K 33/06 (2013.01 - EP); A61K 33/24 (2013.01 - EP US); A61K 38/28 (2013.01 - EP)
Citation (search report)
See references of WO 2011149337A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
DOCDB simple family (application)
NL 2010050326 W 20100528; EP 10726622 A 20100528